Name
DAVH
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for DAVH
Name
Alternate Names
Androfluorene
Android-F
Anrosterolo
Fluo-testin
Fluoximesterone
Flusteron
Flutestos
Halodrin
Halotestin
Neo-Ormonal
Ora-Testryl#
Oralsterone
Oratestin
Testoral
Ultandren
Abbreviations
FLU
FXM
HAL
Category
Hormones and hormonal mechanisms
Subcategory
Androgen
NSC Number
012165
12165
Primary Site
Breast cancer
Histology
None
Remarks
A synthetic androgenic anabolic steroid used in the treatment of male hypogonadism and in the palliative therapy of inoperable female breast cancer in selected patients, administered orally.
Coding
This drug should be coded
Name
Alternate Names
Dibromdulcit
Elobromol
Mitolac
Mitolactol
Abbreviations
DBD
Category
Chemotherapy
Subcategory
Miscellaneous agent
NSC Number
104800
Primary Site
None
Histology
None
Remarks
Miscellaneous agent
Coding
This drug should be coded
Name
Alternate Names
14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin
Abbreviations
ADM
ADR
ADRI
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
123127
Primary Site
Histology
None
Remarks
Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic
Coding
This drug should be coded
Name
Alternate Names
Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin
Abbreviations
LCR
VCR
VNCR
Category
Chemotherapy
Subcategory
Plant alkyloid--antimetabolite
NSC Number
067574
67574
Primary Site
None
Histology
None
Remarks
Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.
Coding
This drug should be coded